Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer.

Xuan HanWu-Hu ZhangHe-Li GaoTian-Jiao LiHua-Xiang XuHao LiPeng-Cheng LiXu WangXian-Jun YuWen-Quan WangLiang Liu

Published in: Journal of clinical laboratory analysis (2022)

Neoadjuvant chemotherapy endows CD9 with a significant prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
sentinel lymph node
bone marrow
nk cells
radiation therapy
early stage